About Katholisches Klinikum Bochum gGmbH
Clinical Trials at Katholisches Klinikum Bochum gGmbH
During the past decade, Katholisches Klinikum Bochum gGmbH conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Katholisches Klinikum Bochum gGmbH" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials
sponsored, "Mandos LLC" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "EuMelaReg gGmbH"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Katholisches Klinikum Bochum gGmbH"
#1 collaborator was "Gesellschaft für Therapieforschung mbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Katholisches Klinikum Bochum gGmbH
According to Clinical.Site data, the most researched conditions in "Katholisches Klinikum Bochum gGmbH" are
"Hidradenitis Suppurativa" (4 trials), "Niemann-Pick Disease, Type C" (2 trials), "Advanced or Metastatic Colorectal Cancer" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Katholisches Klinikum Bochum gGmbH" in a lesser frequency.
Clinical Trials Intervention Types at Katholisches Klinikum Bochum gGmbH
Most popular intervention types in "Katholisches Klinikum Bochum gGmbH" are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Spesolimab" (2 trials), "Adalimumab" (1 trials) and "Adrabetadex" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katholisches Klinikum Bochum gGmbH
The vast majority of trials in "Katholisches Klinikum Bochum gGmbH" are
14 trials for "All" genders.
Clinical Trials Status at Katholisches Klinikum Bochum gGmbH
Currently, there are NaN active trials in "Katholisches Klinikum Bochum gGmbH".
undefined are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Katholisches Klinikum Bochum gGmbH,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Katholisches Klinikum Bochum gGmbH, 2 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Katholisches Klinikum Bochum gGmbH
Katholisches Klinikum Bochum gGmbH has several departments that took part in Clinical trials: "St. Josef-Hospital, Klinik für Neurologie" - 10 trials, "Department of Dermatology, Ruhr University Bochum" - 7 trials, "Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Kliniken der Ruhr-Universität Bochum im St. Maria-Hilf-Krankenhaus" - 2 trials, "St. Josef-Hospital, Neurologische Klinik der Ruhr-Uni; Huntington-Center NRW, Abt. Neurodegeneration" - 2 trials, "Department of Medicine I; University Hospital St. Josef Hospital" - 2 trials